Senators Grill Pharmaceutical CEOs about High Drug Prices

The hearing marks the first time lawmakers have called the industry's top executives to account for rising prices.

  • Published 26 February 2019

This article was republished here with permission from The Associated Press, however it is no longer available to read on

WASHINGTON (AP) — Senators grilled CEOs of seven major drug companies on Tuesday over high prescription drug prices that are a drain on Medicare and Medicaid and a burden to millions of Americans. The extraordinary public accounting was a sign that Congress and the White House are moving toward legislation this year to curb costs. As the Finance Committee hearing got underway, Chairman Charles Grassley, R-Iowa, pointedly reminded the executives that it’s a crime to… Read at AP News